1
项与 CART-PSMA-TGFβRDN cells(University of Pennsylvania) 相关的临床试验Phase I Study of CART-PSMA-TGFβRDN Cells in Patients With Advanced Castrate Resistant Prostate Cancer
This is a single center, single arm Phase I study to establish the safety and feasibility of intravenously administered lentivirally transduced dual PSMA-specific/ TGFβ-resistant CAR modified autologous T cells (CART-PSMA-TGFβRDN cells) in patients with metastatic castrate resistant prostate cancer.
100 项与 CART-PSMA-TGFβRDN cells(University of Pennsylvania) 相关的临床结果
100 项与 CART-PSMA-TGFβRDN cells(University of Pennsylvania) 相关的转化医学
100 项与 CART-PSMA-TGFβRDN cells(University of Pennsylvania) 相关的专利(医药)
100 项与 CART-PSMA-TGFβRDN cells(University of Pennsylvania) 相关的药物交易